Sign in
Not yet recruitingPhase 2

Influence of Dexmedetomidine on the Human Glymphatic Cerebrospinal Fluid Flow, Neural Activity and Cerebral Blood Flow in Functional Magnetic Resonance Imaging (GlymphDex)

Key facts

Who runs it
Helsinki University Central Hospital
Where
Finland1 site in 1 countryChoose a country to see its sites
Status
Not yet recruiting
Phase
Phase 2
People taking part
20 people, planned
Started
1 Sept 2023
Planned end
31 Dec 2024
Type of study
Interventional
Record updated
16 February 2026

Who can take part

Age
18 years to 64 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 30 criteriaShow less

Who can take part

  • Fluent Finnish skills
  • Head circumference max 59 cm
  • Right-handedness
  • Age 18-45 years
  • Healthy
  • Normal baseline ECG
  • Normal blood pressure
  • Normal SpO2
  • No signs of substance abuse
  • Acceptable values in laboratory tests
  • Normal weight (BMI 18.5-30 kg/m2)

Who cannot take part

  • Previous history of intolerance to the study drug or related compound/additive
  • Blood donation within 3 months prior to and during the study
  • Previous or present alcoholism or drug abuse or tendency to drug or alcohol abuse
  • Smoking during one month before the study or during the study
  • Existing regular medication (incl contraception)
  • Participation in any other clinical study involving investigational or marketed drug products concomitantly or within 3 months prior to entry to this study
  • Known history of snoring or obstructive sleep apnea
  • Tinnitus or hearing impairment
  • Strong susceptibility to allergic reactions
  • Known history of significant anaesthetic complication
  • Chronic sleep disturbance
  • Low body weight (< 50 kg) or BMI < 18.5 kg/m2 or BMI > 30 kg/m2
  • Inability or difficulty of lying or sleeping in horizontal supine position
  • Forearm veins evaluated difficult to cannulate
  • Any contraindication to MRI
  • Strong susceptibility to nausea
  • Airway management is evaluated difficult
  • Gastroesofageal reflux
  • Pregnancy, planned pregnancy, or lactation

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 64 years old?

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The aim of this study is to characterize brain pulsations, blood flow, and cerebrospinal fluid flow using functional MRI in different states of consciousness and couple these to neural activity in electroencephalography in the awake brain and under different levels of dexmedetomidine sedation.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Criteria questions
Built from 2023-507215-35-00, who can take part
Record updated
16 February 2026